You just read:

Parent Project Muscular Dystrophy Launches Next Phase of Genetic Testing Program, Decode Duchenne in collaboration with BioMarin Pharmaceutical Inc., PTC Therapeutics, and Sarepta Therapeutics

News provided by

Parent Project Muscular Dystrophy

Sep 30, 2015, 12:00 ET